Spotlight Growth
No Result
View All Result
Monday, July 4, 2022
  • Login
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Market News

Europe Shows Signs of Warming to SPACs

by admin
September 22, 2020
in Market News
0
European SPACs Increase Demand

European SPACs Increase Demand

In a sign of shifting perceptions, the European market appears more amenable to the idea of special purpose acquisition companies, or SPACs. This specific type of IPO exploded in popularity within the United States over recent years. Yet, the European market lagged due to a combination of regulation and differing attitudes on investing. As the global economy enters a state of flux, investors looking for new revenue streams are branching out – with Europe looking towards SPACs.

The European economy continues to see better-than-expected results, despite the on-going pandemic. At a more individual level, countries dependent on tourism continue to flounder. Manufacturing and financial countries are more than making up the slack – and it is here that SPACs are taking root. The United Kingdom’s London Stock Exchange appears poised to actively support the SPAC market. Considering Brexit and the complicated relationship between the U.K. and the Eurozone, this may be less of an indicator than it would have been a few years ago.

What Are SPACs?

Special Purpose Acquisition Companies offer investors a means to generically invest in new startups. Rather than place their confidence in a specific IPO, investors fund a board of experts that subsequently searches for acquisition opportunities. SPACs thrive when liquidity is high, profiting from the reputation of the board in charge.

Source: spacdata.com
Source: spacdata.com

The United States represents a liberal investing market with looser regulations. This, in turn, created an investor class that thrives on speculation. In contrast, tighter regulations and more effective government agencies in Europe can prevent more speculative investments – including SPACs, to a degree. The recent warming to SPACs comes as European investors take advantage of the shaky global situation.

Confidence, Panic and Blind Faith

The current SPAC explosion comes as investor confidence reaches a fever pitch. The coronavirus pandemic did irreparable damage to many sectors of the economy. Despite this, most stock indices continue to post record highs after a sharp recovery. This is almost entirely due to a policy of “unlimited quantitative easing” put in place by the U.S. government. While it temporarily held the economy aloft, the long-term implications are potentially disastrous.

As investors continue to rake in profits, small businesses continue to crumble, and the overall economy continues to be displaced from the stock market. Large scale investors, protected from bad choices by the treasury policy, sink money into any potential revenue driver. It is important to remember that SPACs are not a sure thing – and when they fail, they fail catastrophically.

Article By: Adam Stone

Tags: acquisitioncommon stockemerging growtheurope SPACsinvestinginvestmentIPOsmarket newsmarket watchMergerNASDAQnewspublic companysalesservicessmall cap companiessmall cap stockssmall capsSPAC IPOsSPACsspecial purpose acquisition companySpotlight GrowthSpotlight Growth Stocksstock marketstockstradingWall Street
Plugin Install : Widget Tab Post needs JNews - View Counter to be installed
  • Trending
  • Comments
  • Latest
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

November 22, 2021
Alfi NASDAQ ALF Ridesharing Tablet Rollout Spotlight Growth

Alfi, Inc. (NASDAQ: ALF) Climbs 51% After Entering Into Agreement with Miami-Based Fulfillment & Distribution Center For its Ridesharing Digital Tablet Rollout

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022
Ayurcann CSE AYUR OTCQB AYURF July Product Rollout Canada Spotlight Growth

Ayurcann (CSE: AYUR) (OTCQB: AYURF) Prepares for July New Product Rollout as Distribution Expansion Continues Across Canada

June 27, 2022
NeuroSense Therapeutics NASDAQ NRSN Stage III ALS Biomarker Study Spotlight Growth

NeuroSense Therapeutics (NASDAQ: NRSN) Details PrimeC’s Positive Results from Stage III ALS Biomarker Study

June 27, 2022

Recent News

Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us
Spotlight Growth

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested